Research Working Group      Policy Development Working Group      International Affairs Working Group

Linking Researchers and Industry

  • The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
  • The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
  • The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine.
  • The VPH institute has its origins in a European Commission endorsed research area on computer modeling and simulation and has been active for over 10 years.
  • This partnership of industry and researchers allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market. 

Avicenna Alliance news

Member of European Parliament Nicola Caputo supports the international cooperation on in silico medicine

MEP Nicola Caputo, from the Alliance of Socialists and Democrats, agreed to sign - along with...

find out more ›

Digital Twin & CM&S to feature in Horizon Europe core text

On 17 April, the European Parliament adopted the partial agreements resulting from interinstitutional negotiations on the two Horizon Europe...

find out more ›

Launch of the MOBILISE-D Project

On 11 April, the project MOBILISE-D, a project funded by the European Innovative Medicines Initiative 2 Joint Undertaking, was launched with the aim to revolutionise...

find out more ›

Show all activites